Michael E. Hurwitz
Impact in
Papers in
- Oncology 47
- Cancer Immunotherapy and Biomarkers 34
- CAR-T cell therapy research 15
-
- Renal cell carcinoma treatment 24
- Prostate Cancer Treatment and Research 6
- Co-authors
- Gerd A. Blobel (1 shared paper)Harriet M. Kluger (20 shared papers)Mario Sznol (11 shared papers)Bryden Considine (5 shared papers)Günter Blobel (1 shared paper)H. Robert Horvitz (4 shared papers)Caterina Strambio‐De‐Castillia (1 shared paper)Gian Garriga (3 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Journal for ImmunoTherapy of Cancer (6 papers)Blood (3 papers)The American Journal of Surgery (3 papers)Clinical Genitourinary Cancer (3 papers)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Michael E. Hurwitz
69 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Aging 45
- Oncology 582
- Immunology 290
- Pulmonary and Respiratory Medicine 323
- Cancer Research 128
Countries citing papers authored by Michael E. Hurwitz
This map shows the geographic impact of Michael E. Hurwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Hurwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Hurwitz more than expected).
Fields of papers citing papers by Michael E. Hurwitz
This network shows the impact of papers produced by Michael E. Hurwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Hurwitz. The network helps show where Michael E. Hurwitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Hurwitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 169 | |
| 2 | 2020 | 65 | |
| 3 | 1995 | 64 | |
| 4 | 1998 | 54 | |
| 5 | 1994 | 47 | |
| 6 | 2022 | 47 | |
| 7 | 2020 | 42 | |
| 8 | 2023 | 40 | |
| 9 | 2018 | 40 | |
| 10 | 2009 | 38 | |
| 11 | 2019 | 36 | |
| 12 | 2019 | 31 | |
| 13 | 2009 | 30 | |
| 14 | 2009 | 30 | |
| 15 | 2022 | 27 | |
| 16 | 2009 | 25 | |
| 17 | 2015 | 24 | |
| 18 | 2022 | 21 | |
| 19 | 2023 | 19 | |
| 20 | 1992 | 15 |
About Michael E. Hurwitz
Michael E. Hurwitz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Surgery, having authored 76 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (34 papers), Renal cell carcinoma treatment (24 papers), CAR-T cell therapy research (15 papers), Bladder and Urothelial Cancer Treatments (9 papers), Immunotherapy and Immune Responses (8 papers), Cancer Genomics and Diagnostics (6 papers), Prostate Cancer Treatment and Research (6 papers) and Economic and Financial Impacts of Cancer (5 papers). The work is most often cited by research in Aging (45 citations), Oncology (582 citations), Immunology (290 citations), Pulmonary and Respiratory Medicine (323 citations) and Cancer Research (128 citations). Michael E. Hurwitz has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Gerd A. Blobel, Harriet M. Kluger, Mario Sznol, Bryden Considine, Günter Blobel, H. Robert Horvitz, Caterina Strambio‐De‐Castillia, Gian Garriga, Adi Diab and Laird Bloom. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Blood, The American Journal of Surgery and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.